Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers

Development and validation of a rapid and sensitive UPLC–MS/MS method for determination of uracil and dihydrouracil in human plasma

(2016) Bart A.W. Jacobs et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase-driven adaptive dosing of 5-FU in patients with digestive cancer

(2015) Manon Launay et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Genotyping of a family with a novel deleteriousDPYDmutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio

(2015) F Thomas et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2R allele

(2015) Didier Meulendijks et al.   INTERNATIONAL JOURNAL OF CANCER

Improved pharmacodynamic assay for dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells

(2015) Dick Pluim et al.   Bioanalysis

cocor: A Comprehensive Solution for the Statistical Comparison of Correlations

(2015) Birk Diedenhofen et al.   PLoS One

Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

(2014) Dan Rosmarin et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio

(2014) Johanna Sistonen et al.   PHARMACOGENOMICS

Pharmacodynamic assay of thymidylate synthase activity in peripheral blood mononuclear cells

(2013) Dick Pluim et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Correction of peripheral blood mononuclear cell cytosolic protein for hemoglobin contamination

(2013) Dick Pluim et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity

(2013) A Loganayagam et al.   BRITISH JOURNAL OF CANCER

Correlation between Thymidylate Synthase Gene Variants, RNA and Protein Levels in Primary Colorectal Adenocarcinomas

(2013) MH Kristensen et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors

(2012) Valentina Monica et al.   LUNG CANCER

Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer

(2011) M. J. Deenen et al.   CLINICAL CANCER RESEARCH

PharmGKB summary

(2011) Caroline F. Thorn et al.   Pharmacogenetics and Genomics

Chronotherapy and the molecular clock: Clinical implications in oncology☆

(2010) Pasquale F. Innominato et al.   ADVANCED DRUG DELIVERY REVIEWS

Self-sustained circadian rhythm in cultured human mononuclear cells isolated from peripheral blood

(2009) Takashi Ebisawa et al.   NEUROSCIENCE RESEARCH

Capecitabine: have we got the dose right?

(2008) Rachel Midgley et al.   Nature clinical practice. Oncology